logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 9 of 9 Items
Showing 1 - 9 of 9 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l’essai proches)

Watson CH, Gsell PS, Hall Y, Camacho A, Riveros X,  et al.
2024-11-07 • BMC Medicine
2024-11-07 • BMC Medicine

BACKGROUND

Zaire Ebolavirus disease (EVD) outbreaks can be controlled using rVSV-ZEBOV vaccination and other public health measures. People in high-risk areas m...

Journal Article
|
Commentary

Revisiting the minimum incubation period of Zaire ebolavirus

Kofman AD, Haberling DL, Mbuyi G, Martel LD, Whitesell AN,  et al.
2023-08-18 • Lancet Infectious Diseases
2023-08-18 • Lancet Infectious Diseases
Journal Article
|
Letter

Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa

Carroll MW, Matthews DA, Hiscox JA, Elmore MJ, Pollakis G,  et al.
2015-06-17 • Nature
2015-06-17 • Nature
West Africa is currently witnessing the most extensive Ebola virus (EBOV) outbreak so far recorded. Until now, there have been 27,013 reported cases and 11,134 deaths. The origin of the ...
Journal Article
|
Research

Pregnancy outcomes after a mass vaccination campaign with an oral cholera vaccine in Guinea: a retrospective cohort study

Grout L, Martinez-Pino I, Ciglenecki I, Keita S, Diallo AK,  et al.
2015-12-29 • PLOS Neglected Tropical Diseases
2015-12-29 • PLOS Neglected Tropical Diseases
INTRODUCTION
Since 2010, WHO has recommended oral cholera vaccines as an additional strategy for cholera control. During a cholera episode, pregnant women are at high risk of complic...
Journal Article
|
Research

Control of Ebola virus disease outbreaks: Comparison of health care worker-targeted and community vaccination strategies

Robert A, Camacho A, Edmunds WJ, Baguelin M, Muyembe JJT,  et al.
2019-03-02 • Epidemics
2019-03-02 • Epidemics
Health care workers (HCW) are at risk of infection during Ebola virus disease outbreaks and therefore may be targeted for vaccination before or during outbreaks. The effect of these stra...
Journal Article
|
Letter

Detection of Marburg virus disease in Guinea

Koundouno FR, Kafetzopoulou LE, Faye M, Renevey A, Soropogui B,  et al.
2022-06-30 • New England Journal of Medicine
2022-06-30 • New England Journal of Medicine
Journal Article
|
Research

Efficacy and Effectiveness of an rVSV-Vectored Vaccine in Preventing Ebola Virus Disease: Final Results from the Guinea Ring Vaccination, Open-Label, Cluster-Randomised Trial (Ebola Ça Suffit!)

Henao-Restrepo AM, Camacho A, Longini I, Watson CH, Edmunds WJ,  et al.
2017-02-01 • Lancet
2017-02-01 • Lancet
BACKGROUND
rVSV-ZEBOV is a recombinant, replication competent vesicular stomatitis virus-based candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus. We tested the ...
Journal Article
|
Research

Clinical predictor of mortality in patients with Ebola virus disease

Barry M, Traore FA, Sako FB, Sylla D, Kpamy D,  et al.
2015-03-13 • Clinical Infectious Diseases
2015-03-13 • Clinical Infectious Diseases
In an observational cohort study including 89 Ebola patients, predictor factors of death were analyzed. The crude mortality rate was 43.8%. Myalgia (OR; 4.04; P=0.02), hemorrhage (OR=3.5...
Journal Article
|
Short Report

Emergence of Zaire Ebola Virus Disease in Guinea - Preliminary Report

Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L,  et al.
2014-10-09 • New England Journal of Medicine
2014-10-09 • New England Journal of Medicine
In March 2014, the World Health Organization was notified of an outbreak of a communicable disease characterized by fever, severe diarrhea, vomiting, and a high fatality rate in Guinea. ...